Plasminogen activator inhibitor-1 (PAI-1) and urokinase plasminogen activator (uPA) in sputum of allergic asthma patients.

Similar Items

• Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas.
  od: Bouchet, C., i dr.
  Izdano: (1994)
• Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) in breast cancer - correlation with traditional prognostic factors
  od: Lampelj, Maja, i dr.
  Izdano: (2015)
• Introduction of an RRHR motif into chicken urokinase-type plasminogen activator (ch-uPA) confers sensitivity to plasminogen activator inhibitor (PAI)-1 and PAI-2 and allows ch-uPA-mediated extracellular matrix degradation to be controlled by PAI-1
  od: Sipley, John D., i dr.
  Izdano: (1997)
• Microglia and the urokinase plasminogen activator receptor/uPA system in innate brain inflammation
  od: Cunningham, Orla, i dr.
  Izdano: (2009)
• Expression of Urokinase‐Type Plasminogen Activator (uPA), its Receptor (uPAR), and Inhibitor (PAI‐1) in Human Breast Carcinomas and Their Clinical Relevance
  od: Andres, Sarah A., i dr.
  Izdano: (2012)